|
TUBGCP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.17729999999872E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.86720000000729E-05 |
| Normal-vs-Stage2 |
1.664240E-01 |
| Normal-vs-Stage3 |
8.462100E-02 |
| Normal-vs-Stage4 |
1.083350E-01 |
| Stage1-vs-Stage2 |
7.428600E-01 |
| Stage1-vs-Stage3 |
3.317200E-01 |
| Stage1-vs-Stage4 |
7.636800E-01 |
| Stage2-vs-Stage3 |
7.225000E-01 |
| Stage2-vs-Stage4 |
7.009800E-01 |
| Stage3-vs-Stage4 |
3.664200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.10119999999714E-05 |
| Normal-vs-AfricanAmerican |
1.603960E-02 |
| Normal-vs-Asian |
9.648400E-02 |
| Caucasian-vs-AfricanAmerican |
7.054800E-01 |
| Caucasian-vs-Asian |
4.911000E-01 |
| AfricanAmerican-vs-Asian |
4.563200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.30100000012612E-07 |
| Normal-vs-Female |
4.610600E-01 |
| Male-vs-Female |
5.897200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.677000E-03 |
| Normal-vs-Extreme_Weight |
8.11640000000224E-05 |
| Normal-vs-Obese |
8.903500E-02 |
| Normal-vs-Extreme_Obese |
1.159540E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.314400E-01 |
| Normal_Weight-vs-Obese |
2.456400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.445000E-01 |
| Extreme_Weight-vs-Obese |
1.267040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.221400E-01 |
| Obese-vs-Extreme_Obese |
1.594570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.283600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.135690E-02 |
| Normal-vs-Age(61-80Yrs) |
2.11739999999017E-05 |
| Normal-vs-Age(81-100Yrs) |
1.895820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.229600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.526600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.898100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.885700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.542200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.410200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.78049999999664E-05 |
| Normal-VS-Type2 PRCC |
4.140100E-03 |
| Normal-VS-KIRP CIMP |
4.629800E-01 |
| Normal-VS-Unclassified PRCC |
1.023390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.974000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.527200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.831600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.500800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.285400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.383000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49660000003937E-06 |
| Normal-vs-N1 |
1.357980E-01 |
| Normal-vs-N2 |
6.077200E-01 |
| N0-vs-N1 |
1.929170E-01 |
| N0-vs-N2 |
8.035600E-01 |
| N1-vs-N2 |
8.686800E-01 |
|
|
